TIDMEKF

RNS Number : 4054V

EKF Diagnostics Holdings PLC

15 April 2016

15 April 2016

EKF Diagnostics Holdings plc

(the "Company" or the "Borrower")

Notice of loan redemption

EKF Diagnostics Holdings plc (AIM: EKF) announces that it has served notice to redeem the GBP3 million convertible loan ("Convertible Loan") from Zwanziger Family Ventures LLC (the "Lender").

Under the terms of the convertible loan the Borrower is entitled to repay the entire Convertible Loan giving the Lender at least 20 days' notice. The Lender has the right to serve a conversion notice on the Borrower at any time giving not less than 10 days' notice. If the Convertible Loan is converted, at the option of the Lender, the conversion price per share is 14.4 pence per share (being a 20 per cent. premium to the Company's share price on 22 December 2015).

North Atlantic Smaller Companies Investment Trust PLC ("NAIT") has agreed to provide to a loan facility of GBP3 million to EKF with interest accruing a LIBOR plus 5%, payable every 6 months in arrears, with security over the assets of the Company ranking behind HSBC (the "Loan"). There is no early re-payment penalty or ability to convert into ordinary shares of the Company.

Christopher Mills as non-executive Chairman of the Company. Harwood Capital LLP is investment manager to NAIT. Harwood Capital LLP is a limited liability partnership of which Christopher Mills is a partner and Chief Investment Officer. Therefore the Loan constitutes a related party transaction. EKF's Directors, with the exception of Christopher Mills, consider, having consulted with its nominated adviser, that the terms of the transaction are fair and reasonable insofar as its shareholders are concerned.

 
EKF Diagnostics Holdings                          Tel: 029 2071 0570 
 plc 
Julian Baines, CEO 
Richard Evans, FD & 
 COO 
 
Panmure Gordon (UK)                               Tel: 020 7886 2500 
 Limited 
Robert Naylor (Corporate 
 Finance) 
Paul Fincham (Corporate 
 Finance) 
 
Walbrook PR Limited         Tel: 020 7933 8780 or ekf@walbrookpr.com 
Paul McManus                                      Mob: 07980 541 893 
Lianne Cawthorne                                  Mob: 07584 391 303

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCZELFFQZFEBBL

(END) Dow Jones Newswires

April 15, 2016 10:53 ET (14:53 GMT)

Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Ekf Diagnostics Charts.
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Ekf Diagnostics Charts.